AnaptysBio (ANAB) earnings, Sep 21, 2026: EPS +672%, stock −0.5%
In brief
AnaptysBio reported on Sep 21, 2026. Earnings per share changed +672% year over year, 1,198.9% above the estimate; revenue +23%. The stock opened with a +1.4% gap and closed the day −0.5% (Sep 21, 2026). The stock is now 37.0% below its 52-week high, +89.9% over 12 months.
EPS vs estimate+1,198.9%
EPS, YoY+672%
Revenue, YoY+23%
Gap · day+1.4% · −0.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2025 | +4.5% | −9.6% |
| May 12, 2026 | −0.9% | −3.4% |
| Sep 21, 2026 | +1.4% | −0.5% |
Next-quarter estimates, ratings and the ANAB chart are in the terminal.
Open the terminalFAQ
When is AnaptysBio's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did AnaptysBio stock react to the report?
Opening gap +1.4%, day's result −0.5%.
Did AnaptysBio's earnings grow?
Earnings per share rose 672% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.